Work

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis

Year: 2021

Type: article

Study design: Clinical Trial

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2021.109074

Authors: Derek Blevins, Chamindi Seneviratne, Xin-Qun Wang, Bankole A. Johnson, Nassima Ait-Daoud

Institutions: Columbia University Irving Medical Center, New York State Psychiatric Institute, Columbia University, University of Maryland, Baltimore, University of Virginia

Language: English

Topic: Substance Abuse Treatment and Outcomes

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse

Awards: Genomic Predictors of Placebo response in Phase II AUD trials, New Medication Treatments for Stimulant Dependence, G760963938, Translational Clinical Research Fellowship on Substance Use Disorders

OpenAlex ID: W3202292671

FWCI: 1.069

Cites: 56

Cited by: 11

Related to: 10